Three-Way Medication Comparison: Side Effects Explained
Wegovy vs Saxenda Side Effects: Understanding the GLP-1 Differences
When comparing Wegovy vs Saxenda side effects, both medications target GLP-1 receptors but differ significantly in their profiles. Wegovy (semaglutide) is administered once weekly, whilst Saxenda (liraglutide) requires daily injections, which can influence the frequency and intensity of side effects experienced. The most commonly reported side effects for Wegovy include nausea, diarrhoea, vomiting, and constipation, typically occurring during the initial dose escalation phases. Saxenda shares similar gastrointestinal effects but may present them more consistently due to its daily dosing schedule.
Mounjaro (tirzepatide) introduces a different mechanism as a dual GIP and GLP-1 receptor agonist, potentially offering different tolerability characteristics. Clinical studies suggest that Mounjaro's dual action may result in similar gastrointestinal side effects to Wegovy, but the dual mechanism could influence how patients respond individually. At EverydayMeds, we stock both Wegovy and Mounjaro, allowing our prescribers to recommend the most appropriate option based on your medical history and side effect tolerability. Both medications require clinical assessment and ongoing monitoring as prescription-only medicines.
Pricing Comparison: Wegovy vs Mounjaro Side Effects and Value
Understanding the cost implications when comparing Wegovy vs Saxenda side effects alongside Mounjaro helps inform your decision. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance dose 2.4mg (£209.99). Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide convenient dose progression whilst managing potential side effects. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices.
Mounjaro follows a different dosing schedule with six available strengths from 2.5mg to 15mg, each priced competitively compared to other weight management options. The medication costs reflect the different manufacturing processes and mechanisms involved - Wegovy's semaglutide production differs from Mounjaro's tirzepatide synthesis. When considering side effect management, our 2-pen and 3-pen bundles allow patients to maintain consistency during challenging adjustment periods. The Ultimate Stability Trio (2.4mg ×3) for £649.99 provides three months of maintenance supply, supporting long-term side effect adaptation and treatment success.
Clinical Evidence: Wegovy vs Saxenda Side Effects in Research
Clinical trials demonstrate different side effect profiles when comparing Wegovy vs Saxenda side effects in controlled settings. The STEP programme for Wegovy, including the landmark Wilding et al., NEJM, 2021 study, reported that gastrointestinal side effects were generally mild to moderate and decreased over time with appropriate dose escalation. Patients in STEP trials experienced nausea in approximately 44% of cases, typically resolving within the first 8-12 weeks of treatment.
Mounjaro's SURMOUNT trials revealed similar gastrointestinal tolerability patterns, though the dual receptor mechanism may influence individual responses differently. The tirzepatide clinical programme suggests that side effect profiles may vary based on the dual GIP and GLP-1 activation compared to single GLP-1 targeting medications. Both Wegovy and Mounjaro demonstrate that most side effects occur during initial dose escalation phases, emphasising the importance of following prescribed titration schedules.
How Wegovy Works: Mechanism Behind Side Effects
Wegovy functions as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate blood sugar and gastric emptying, which explains many observed side effects. The medication binds to GLP-1 receptors in the pancreas, stomach, and brain, slowing gastric emptying and promoting satiety - mechanisms directly linked to gastrointestinal side effects like nausea and delayed digestion. This delayed gastric emptying, whilst beneficial for appetite control, can initially cause discomfort as the digestive system adapts to the altered timing. The brain-based appetite centres targeted by Wegovy may also influence taste preferences and food aversion, contributing to treatment success but potentially causing temporary dietary adjustments. Understanding this mechanism helps patients anticipate and manage side effects more effectively, particularly when comparing Wegovy vs Saxenda side effects and considering Mounjaro's additional GIP receptor activation.
EverydayMeds Ordering Process: Managing Side Effects from Day One
Our streamlined ordering process for both Wegovy and Mounjaro begins with a comprehensive 3-minute online clinical assessment that specifically evaluates your potential for experiencing side effects. Our registered prescribers review your medical history, current medications, and previous experiences with similar treatments to determine the most appropriate starting dose and escalation schedule. Following prescriber approval (standard 3 working days, express 24-hour service available), medications are dispatched via temperature-controlled, next-day delivery to maintain medication integrity. Each shipment includes detailed side effect management guidance and direct access to our clinical support team throughout your treatment journey. This comprehensive approach ensures that whether you're comparing Wegovy vs Saxenda side effects or considering Mounjaro, you receive appropriate clinical oversight as required for these prescription-only medicines.
Storage and Practical Considerations: Side Effect Management
Proper storage significantly impacts medication effectiveness and may influence side effect experiences when comparing these weight management options. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel convenience with 6 weeks room temperature stability below 30°C, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen system used for Wegovy provides consistent, accurate dosing that supports the gradual escalation schedule designed to minimise side effects - starting at 0.25mg weekly and progressing through 0.5mg, 1mg, 1.7mg to maintenance 2.4mg over 16 weeks. This careful dose escalation, combined with proper storage maintaining medication potency, optimises tolerability compared to rushing dose increases. Patients managing side effects benefit from maintaining consistent injection timing and rotating injection sites as recommended, practices that our clinical team provides detailed guidance on throughout treatment.
Wegovy vs Saxenda Side Effects: Dual Receptor Advantages
The unique positioning of comparing Wegovy vs Saxenda side effects alongside Mounjaro reveals important therapeutic distinctions that influence treatment selection. Mounjaro's dual GIP and GLP-1 receptor agonism may offer different tolerability characteristics compared to single GLP-1 targeting medications like Wegovy and Saxenda. Some patients who experience persistent gastrointestinal side effects with traditional GLP-1 medications may find the dual mechanism more tolerable, whilst others respond better to the established semaglutide profile. This individual variation emphasises why having access to both options through EverydayMeds provides significant treatment flexibility.
The weekly dosing schedule shared by Wegovy and Mounjaro contrasts with Saxenda's daily requirement, potentially reducing injection-related side effects and improving long-term adherence. Clinical experience suggests that patients comparing Wegovy vs Saxenda side effects often prefer the convenience and potentially reduced injection site reactions associated with less frequent dosing. Our clinical team evaluates these factors during assessment, ensuring that medication selection considers both efficacy potential and side effect tolerability for your individual circumstances.
Choose Your Ideal Weight Management Partner
Both Wegovy and Mounjaro are available through EverydayMeds' comprehensive service, supported by our registered pharmacy credentials (GPhC #9012878) and expert clinical oversight. New customers can access competitive pricing using code FIRST40, whilst returning customers benefit from code DOSE25 applied at checkout. Our clinical team provides ongoing support throughout your treatment, helping manage any side effects and optimise your weight management journey alongside a reduced-calorie diet and increased physical activity. Whether you're specifically concerned about Wegovy vs Saxenda side effects or exploring Mounjaro's dual mechanism approach, our prescribers can guide you toward the most appropriate choice for your individual needs. Visit our weight management collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and take the first step toward effective, medically supervised weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
